Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome-Reference-Cited by-同舟云学术

Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome

Published:2015-06-05 Issue:2 Volume:80 Page:242-252
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kreeftmeijer-Vegter A. R.¹²,Dorlo T. P. C.¹³,Gruppen M. P.⁴,de Boer A.¹,de Vries P. J.²⁵

Affiliation:

1. Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology; Utrecht University; P.O. Box 80 082 3508 TB Utrecht the Netherlands

2. ACE Pharmaceuticals BV; Schepenveld 41 3891 ZK Zeewolde the Netherlands

3. Department Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

4. Department of Paediatric Nephrology; Emma Children's Hospital/Academic Medical Centre; Amsterdam the Netherlands

5. Department of Internal Medicine; Tergooi Ziekenhuis, Van Riebeeckweg 212 1213 XZ Hilversum the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12607/fullpdf

Reference56 articles.

1. Non-corticosteroid treatment for nephrotic syndrome in children;Hodson;Cochrane Database Syst Rev,2008

2. The management of idiopathic nephrotic syndrome in children;Hodson;Paediatr Drugs,2003

3. Long-term outcome of primary nephrotic syndrome;Koskimies;Arch Dis Child,1982

4. Non-corticosteroid treatment for nephrotic syndrome in children;Hodson;Cochrane Database Syst Rev,2008

5. Treatment of nephrotic syndrome with levamisole;Tanphaichitr;J Pediatr,1980

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study;Pediatric Nephrology;2024-06-01

2. Designing a unique molecular size-dependent approach for determining levamisole via synergizing Rayleigh Scattering response of Cilefa Pink B dye; application to bulk, dosage forms, and biofluids; method greenness evaluation;Talanta Open;2023-08

3. Biowaiver Monograph for Immediate-Release Dosage Forms: Levamisole Hydrochloride;Journal of Pharmaceutical Sciences;2023-03

4. Facile utility of felumin, a biological dye for the first fluorimetric determination of l-tetramisole drug through an “on–off fluorescence” strategy;RSC Advances;2023

5. Levamisole causes a transient increase in plasma creatinine levels but does not affect kidney function based on cystatin C;Pediatric Nephrology;2022-04-13